课题基金 / 基金详情

Administrative Core

Administrative Core
行政核心
批准号:
10897479
负责人:
Robert P Schleimer
金额:
$11.62万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-15 至 2024-07-31
关键词:

项目摘要

项目成果

Robert P Schleimer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT The Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2) is an integrated program of epidemiologists, otolaryngologists, allergists and immunologists in which highly collaborative studies are proposed to better understand the molecular and cellular mechanisms of disease heterogeneity and how these mechanisms translate into clinical phenotypes, natural history and long term outcomes. The program focuses particular attention to CRS without nasal polyps (CRSsNP), a highly prevalent and yet obscure phenotype from the standpoint of our current understanding. Another focus of CRISP2 is to critically evaluate the mechanisms and consequences of comorbid conditions in which patients have both CRS and lung disease such as asthma or bronchiectasis. Yet another theme is to make inroads in our understanding of why women are more significantly impacted by CRS than men. In order to achieve these goals, the investigators that comprise the CRISP2 study team have innovated new assays and approaches to cutting edge studies of pathogenesis and epidemiology and, most importantly, have merged these two disciplines to relate mechanisms to symptoms, severity, history and outcomes of CRS. The Administrative Core (Core A) has as its main functions the goals of providing administrative support for the vigorous integrative efforts of the program, facilitating communication and data sharing, catalyzing publications and reporting of the findings of the work, ensuring that the Chronic Rhinosinusitis Integrative Research Program-2 (CRISP2) promotes an effective training function and organizing the advisory board and the regular meetings of the CRISP2 participating centers and investigators. Core A is also responsible for the preparation of progress reports for the program and overseeing regulatory compliance with various institutional and governmental agencies. Core A will play a central role in promoting synergy and advanced collaborative interactions in the program. We have organized these and other functions into the following specific aims: 1.) To provide central administrative services for CRISP2, including oversight of funds distribution, managing the administrative office, facilitating changes that occur in budget, personnel or scientific direction, overseeing preparation of progress reports and assurance of appropriate compliance with directives from the NIH, NU, UC, G/JHU and local, state and federal agencies. The administrative team is Dr. Schleimer (PI), Ms. Valarie Thomas and Ms. Seletta Nichols (administrators) and Dr. Alfred Rademaker (biostatistician). 2.) To facilitate communications in CRISP2 and organize an advisory board. CRISP2 will have four quarterly meetings each year and will maintain an internet-based cloud communications system. 3.) To disseminate discoveries made by CRISP2. Core A will facilitate manuscript preparation and maintenance of a website. 4.) To encourage training. Core A will support an ongoing grant program for young scholars. 5.) To promote interdisciplinary research. Core A will facilitate interactions of the disciplines and individual investigators that are involved in CRISP2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
Administrative Core
Mechanisms of barrier dysfunction and tissue hyperplasia in CRS
Chronic Rhinosinusitis Integrative Studies Program 2 (CRISP2)
  • 批准号:
    10225446
  • 项目类别:
  • 资助金额:
    $185.28万
  • 财政年份:
    2019
  • 负责人:
    Robert P Schleimer
  • 依托单位:
国内基金
海外基金
胆固醇羟化酶CH25H非酶活依赖性促进乙型肝炎病毒蛋白Core及Pre-core降解的分子机制研究
  • 批准号:
    82371765
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    谭广云
  • 依托单位:
锕系元素5f-in-core的GTH赝势和基组的开发
  • 批准号:
    22303037
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    鲁俊波
  • 依托单位:
基于合成致死策略搭建Core-matched前药共组装体克服肿瘤耐药的机制研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    孙丙军
  • 依托单位:
鼠伤寒沙门氏菌LPS core经由CD209/SphK1促进树突状细胞迁移加重炎症性肠病的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    叶成林
  • 依托单位: